Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2024
Sanofi plans to change hospital drug discount program
22 November 2024 - Drug maker looks to rein in how it gives discounts in program designed to help hospitals that ...
Posted by Michael Wonder on 24 Oct 2024
Driving down the cost of biologics: lessons from a nationalised health care system
18 October 2024 - Few treatments have revolutionised care for people with chronic inflammatory disorders more than biologic and small molecule ...
Posted by Michael Wonder on 18 Oct 2024
Government of Canada announces new appointment to the Patented Medicine Prices Review Board
17 October 2024 - Today, the Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine ...
Posted by Michael Wonder on 17 Oct 2024
Medicare’s first round of drug price negotiation - measuring success
16 October 2024 - The Federal Government has proven that it can navigate the difficult process of identifying drugs for price ...
Posted by Michael Wonder on 10 Oct 2024
Biden-Harris Administration Takes Next Step on Proposed Model to Lower Prescription Drug Costs for People with Medicare
9 October 2024 - Today, the US Department of Health and Human Services, through the Centers for Medicare & Medicaid Services, ...
Posted by Michael Wonder on 04 Oct 2024
HHS releases final guidance for second cycle of historic Medicare drug price negotiation program
2 October 2024 - As part of the continued implementation of the Biden-Harris Administration’s historic prescription drug law, the Inflation Reduction ...
Posted by Michael Wonder on 04 Oct 2024
Blue Shield of California slashes cost of world's best selling drug
1 October 2024 - Non-profit health plan collaborates with Fresenius Kabi and Evio Pharmacy Solutions to purchase FDA approved Humira biosimilar ...
Posted by Michael Wonder on 25 Sep 2024
PhRMA scores a small win in legal challenge to Medicare’s drug price negotiation
20 September 2024 - An appeals court revived the case and sent it back to a lower court in Texas. ...
Posted by Michael Wonder on 22 Sep 2024
Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines
18 September 2024 - Amid debate over potential abuse of the US patent system by the pharmaceutical industry, moves by ...
Posted by Michael Wonder on 21 Sep 2024
FTC accuses drug middlemen of inflating insulin prices
20 September 2024 - Agency files lawsuit alleging firms profited from higher insulin prices. ...
Posted by Michael Wonder on 21 Sep 2024
The price war in weight loss drugs is here
20 September 2024 - Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines. ...
Posted by Michael Wonder on 18 Sep 2024
The ICER developing special report for submission to CMS as part of public comment process on Medicare drug price negotiations
18 September 2024 - Report to reflect legislative specifications in the Inflation Reduction Act and subsequent CMS guidance regarding price ...
Posted by Michael Wonder on 06 Sep 2024
US will still pay at least twice as much after negotiating drug prices
3 September 2024 - The US Government's first ever negotiated prices for prescription drugs are still on average more than ...
Posted by Michael Wonder on 25 Aug 2024
What the newly released Medicare prices for 10 drugs do and don’t tell us
16 August 2024 - CMS needs to beware of unintended consequences that might hamper patient access. ...
Posted by Michael Wonder on 17 Aug 2024
Medicare’s drug price talks are about to get more heated
16 August 2024 - Drug makers and officials are fighting over many aspects of the now-annual negotiations. ...